Price close 16 Nov 2026
- 1M
- +5.6%
- 6M
- +13.6%
- YTD
- +31.3%
- 1Y
- +32.3%
- 3Y
- +51.5%
- 10Y
- +154%
Price change over each period, from daily closes; dividends not included.
Price change over each period, from daily closes; dividends not included.
Schwab US Dividend Equity ETF (SCHD) is a dividend US equity exchange-traded fund from Schwab, tracking the Dow Jones US Dividend 100 Index.
It charges 0.06% a year — $6.00 on $10,000, and holds 102 positions, the ten largest 41.7% of the fund.
Its net assets were $112.3 billion on August 31, 2026; it is the largest of the 15 dividend funds among the 300 largest ETFs.
From the fund's prospectus and its latest holdings (31 Aug 2026), compiled and checked by AapWire.
| Holding | Weight | Weight bar |
|---|---|---|
| Merck & Co Inc MRK | 4.76% | |
| Amgen Inc AMGN | 4.70% | |
| Abbott Laboratories ABT | 4.68% | |
| Coca-Cola Co/The KO | 4.16% | |
| Chevron Corp CVX | 4.01% | |
| Verizon Communications Inc VZ | 3.96% | |
| ConocoPhillips COP | 3.93% | |
| Home Depot Inc/The HD | 3.87% | |
| Procter & Gamble Co/The PG | 3.82% | |
| UnitedHealth Group Inc UNH | 3.82% |
| Health Care | 21.4% |
|---|---|
| Consumer Staples | 19.4% |
| Energy | 15.8% |
| Industrials | 14.7% |
| Financials | 9.5% |
| Consumer Discretionary | 6.7% |
| Communication Services | 6.6% |
| Information Technology | 5.9% |
| Utilities | 0.1% |
The eleven sectors of the company pages: an S&P 500 member counts in its index sector, any other holding in its industry's; shares of the stock that has a sector.
Countries as the fund reports them: US 94.7%, IE 2.8%, CW 2.2%.
| Category | Dividend · US equity |
|---|---|
| Issuer | Schwab |
| Index | Dow Jones US Dividend 100 Index |
| Expense ratio | 0.06% · $6.00 a year on $10,000 |
| Net assets | $112.3B · 31 Aug 2026 |
| Holdings | 102 · ten largest 41.7% |
| Legal form | Registered fund |
| Rank in category | 1 of 15 · by size, among the 300 largest ETFs |
| Year | Total return |
|---|---|
| 2024 | 11.6% |
| 2023 | 4.6% |
| 2022 | -3.2% |
| 2021 | 29.8% |
| 2020 | 15.1% |
| 2019 | 27.3% |
| 2018 | -5.5% |
| 2017 | 20.9% |
| 2016 | 16.3% |
| 2015 | -0.2% |
From the prospectus filed 22 Dec 2025.
SCHD's expense ratio is 0.06% a year, $6.00 on a $10,000 holding, from its latest prospectus.
SCHD tracks the Dow Jones US Dividend 100 Index.
SCHD held 102 positions on August 31, 2026.
Merck & Co Inc (4.8%), Amgen Inc (4.7%), Abbott Laboratories (4.7%), Coca-Cola Co/The (4.2%), Chevron Corp (4.0%).
SCHD is issued by Schwab; it is a registered fund.
In the terminal
The fund's costs and returns are read from its prospectus, its positions from its latest report or its issuer's own file, and its category from what it holds and how it names itself. A figure that cannot be read is left blank. See data and methodology.